Network pharmacology is an emerging area of systematic drug research that attempts to
understand drug actions and interactions with multiple targets. Network pharmacology has …

In recent decades, microarray datasets have played an important role in triple negative
breast cancer (TNBC) detection. Microarray data classification is a challenging process due …

Triple-negative breast cancer (TNBC) is known for its heterogeneous complexity and is often
difficult to treat. TNBC lacks the expression of major hormonal receptors like estrogen …

Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with poor
clinical outcomes and lack of approved targeted therapy. Dysregulated microRNAs …

Background Triple negative breast cancer (TNBC) is a specific subtype of breast cancer with
a poor prognosis due to its aggressive biological behaviour and lack of therapeutic targets …

Background Atrial fibrillation (AF) is the most common arrhythmia with poorly understood
mechanisms. We aimed to investigate the biological mechanism of AF and to discover …

The study aimed to explore the molecular mechanism underlying triple-negative breast
cancer (TNBC) and to identify their potential diagnostic/prognostic biomarkers. The …

Background Aurora kinase B (AURKB) is an important carcinogenic factor in various tumors,
while its role in clear cell renal cell carcinoma (ccRCC) still remains unclear. This study …

Based on the androgen receptor (AR) expression, triple-negative breast cancer (TNBC) can
be subdivided into AR-positive TNBC and AR-negative TNBC, also known as quadruple …

Breast cancer is the most frequent malignant tumor in women, and the estrogen receptor
(ER) plays a vital role in the vast majority of breast cancers. The purpose of the present study …